<p>Johnson & Johnson will not will not be undertaking local trials for its single-shot Covid-19 vaccine in India, the <em>Economic Times</em> reported on Tuesday, citing a company spokesperson.</p>.<p>While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement, according to the <a href="https://bit.ly/3h2x358" target="_blank">report</a>.</p>.<p>The company is exploring how to accelerate the availability of its vaccine in India, the <em>Economic Times</em> said.</p>.<p>J&J did not immediately respond to a <em>Reuters</em> request for comment.</p>
<p>Johnson & Johnson will not will not be undertaking local trials for its single-shot Covid-19 vaccine in India, the <em>Economic Times</em> reported on Tuesday, citing a company spokesperson.</p>.<p>While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement, according to the <a href="https://bit.ly/3h2x358" target="_blank">report</a>.</p>.<p>The company is exploring how to accelerate the availability of its vaccine in India, the <em>Economic Times</em> said.</p>.<p>J&J did not immediately respond to a <em>Reuters</em> request for comment.</p>